|
Monday, March 24 — 8:00 AM — Cotillion South
Click on the numbers in parentheses to display abstracts.
Section E - PULMONARY PATHOLOGY
Chaired by: Douglas Flieder and Joseph Tomashefski
| 8:00 |
Mesotheliomas That Express Epidermal Growth Factor Receptor (EGFR) by Immunohistochemistry Fail To Show EGFR Gene Amplification by FISH Analysis
(1431)
JH Ritter, C Fuller, A Perry
Washington University, Saint Louis, MO; Saint Jude Children's Research Hospital, Memphis, TN
|
| 8:15 |
Simian Virus 40 DNA Sequences Are Uncommon in Human Malignant Mesotheliomas: A PCR Analysis of 89 Cases Using Paraffin Tissue
(1443)
MA Vasef, S Han, K Sheibani
University of Iowa, Iowa City, IA; Western Medical Center, Santa Anna, CA
|
| 8:30 |
SV40 Infection and p16/CDKN2A Deletion as Alternative Mechanisms of p53 and RB Pathway Co-Inactivation in a Series of 65 Mesotheliomas
(1417)
F Lopez-Rios, PB Illei, Z Zhao, V Rusch, MF Zakowski, M Ladanyi
Memorial Sloan-Kettering Cancer Center, New York, NY
|
| 8:45 |
E-Cadherin Is a Useful Immunohistochemical (IHC) Marker for Differentiating Benign from Malignant Mesothelial Proliferations
(1428)
T Pereira, RS Saad, YL Liu, MY Tung, RJ Landreneau, JF Silverman
Allegheny General Hospital, Pittsburgh, PA
|
| 9:00 |
Definitive Diagnosis of Pleural Mesothelioma Can Be Established on a Small Panel of Immunohistochemical Markers Using Logic Regression, a Novel Statistical Method
(1445)
H Yaziji, H Battifora, CE Bacchi, M McIntosh, AM Gown
PhenoPath Laboratories and Immunocytochemistry Research Institute of Seattle, Seattle, WA; Pathology Consultation Services, Los Angeles, CA; UNESP, Botucatu, Brazil; Fred Hutchinson Cancer Research Center, Seattle, WA
|
| 9:15 |
Metastatic Carcinoma Verses Malignant Mesothelioma: Indeterminate Cases
(1400)
TJ Franks, MB Beasley, WD Travis
Armed Forces Institute of Pathology, Washington, DC; Tulane University Medical Center, New Orleans, LA
|
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
|
| 11:00 |
p27 and SKP2 Expression in Non-Small Cell Lung Cancers (NSCLC)
(1408)
TA Jennings, CE Sheehan, B Stringer, S Sadis, J Brownell, M Read, JS Ross
Albany Medical College, Albany, NY; Millennium Pharmaceuticals, Inc., Cambridge, MA
|
| 11:15 |
Significance of Survivin Expression in Non-Small-Cell Lung Cancer(NSCLC): A Tissue Microarray Study
(1437)
DF Tan, YC Piao, Q Li, HK Slocum, T Younis, S Wiseman, JJ Brooks, FZ Li, N Ramnath
Roswell Park Cancer Institute, New York; University of Pennsylvania, Philadelphia
|
| 11:30 |
Tissue Based Molecular Markers Predict Early Metastatic Spread of Nonsmall Cell Lung Cancer
(1432)
E Sasatomi, L Johnson, D Lomago, J Thompson, PA Swalsky, SD Finkelstein, SA Yousem
University of Pittsburgh Medical Center
(UPMC), Pittsburgh, PA
|
| 11:45 |
Non-Small Cell Lung Cancer : Expression of Multiple Polymorphic Metabolizing Genes, p53, bcl2 and Survival
(1405)
AK Haque, A Ginzel, S Khan, W Au, J Xie
UTMB, Galveston, TX
|
|
|
